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Abstract 
Atrial Fibrillation (AF) is the most common cardiac arrhythmia and is associated with a 
drastically increase of mortality risk. Mechanisms underlying the initiation and maintenance 
of AF are not understood yet and current treatments for AF are not completely efficient. 
Most effective one, around 50% of effectiveness, is the catheter ablation therapy but its 
long-term effects are reduced. Target ablation is thought to be a solution if AF focal sources 
were identified. Associated AF biomarkers to identify such zones are shortened action 
potential durations (APDs) and slow conduction velocities (CV). Identification of those 
biomarkers could be made through intracardiac electrogram (EGM) signals, however, they 
are very complex to interpret and there is still no validated method to perform it. 
The aim of this bachelor thesis is to develop and validate a software tool able to obtain APDs 
and CV from intracardiac EGM signals recorded directly from a swine heart. Electrical 
recording results are validated with optical mapping (OM) data recordings. The code was 
implemented with the purpose to work for nearby sinus rhythms, that is when it can be 
useful in clinical application to identify in patients with paroxystic AF the regions associated 
to the trigger of the AF. 
Simultaneous electrical and OM recordings of isolated swine heart are performed in a 
Langendorff system set-up. Software code processes electrical recordings by computing 
APDs with Botteron algorithm and computing phase maps. Once phase maps are obtained, 
trajectories are computed and thus CV. Electrical results are validated with OM data. Two 
catheters of different sizes are tested as well as results using 15 or 5 out of the 15 electrodes 
available in each catheter.  
APDs results were highly accurate, they were very similar to the OM data independently of 
whether catheter or number of electrodes was used. CV results were also similar to the OM 
data, varying inside the acceptable range proposed. Best results of CV were obtained with 
the small catheter and specifically for 5 electrode interpolation. Both APDs and CV results 
did not show statistically significative differences with the analysis of the T-student test. 
It can be concluded that the software code developed in this thesis demonstrates that is 
possible to compute both APD and CV values from intracardiac EGM signals with an 
acceptable accuracy. Optimal results for CV computation were obtained with the small 
catheter (2.5 cm radius) and using only 5 out of the 15 electrodes. This opens new insights 
into the use of EGM signals for the clinical estimation of proarrhythmic areas. 
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Introduction 
Cardiovascular diseases are the major cause of death worldwide [1] causing around 801,000 
deaths in United Stated (US) and more than 1,8 million deaths in the European Union (UE) 
(accounting for 45% and 37% of all death respectively) [2], [3].  Not only a health matter but 
also an economic issue: the total budget spent because of cardiovascular diseases by year 
ascended to approximately €210 billion in EU [2] and $316 billion in US [3]. Arrhythmias are 
a type of cardiovascular disease where the normal heart rhythm is altered. Atrial fibrillation 
(AF) is the most common type of arrhythmia where the heart rhythm is increased and 
electrical activation in atria is produced randomly [4].    
AF affects about the 2% of the global population: over 6 million people in Europe [5] from 
which 1 million affected only in Spain [6]. Moreover, AF incidence is expected to keep 
increasing: after a 13% increase in the last two decades [5] it is expected to be doubled in 
the next 50 years [7] (due to the increased elderly population). On top of that, the presence 
of AF doubles the mortality probability [8]. Thus, investigation is crucial for both more 
specialized and better treatments and for an improvement in prevention. Currently there 
are research lines that are putting a lot of effort on AF investigation. 
Mechanism underlying the trigger and the maintenance of AF are still not clear. Different 
hypothesis state diverse approaches to understand it [9], [10]. However it is clear that 
specific biomarkers are related with the AF: such as slow conduction velocities (CV) [11], 
[12] and shorter action potential duration (APD) [13], [14]. 
Intracardiac electrogram (EGM) signals recorded with catheters might be utilized in 
electrophysiology as an assessment tool and, moreover, further analysis might provide 
information about AF targets during ablation procedures (the ultimate treatment for 
sustained arrhythmias). The problem is that intracardiac EGM signals are complex and its 
interpretation is laborious. Considerable approaches have been done in this field [15], [16]. 
However, the lack of an standard protocol and a correct validation of those analysis lead to 
unrelated results [17]. 
This bachelor thesis aims to develop and validate a software tool to analyze intracardiac 
EGM signals and obtain biomarker measures, as APDs and CV, providing relevant 
information about AF initiation and maintenance.  
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Objectives  
The main goal of this bachelor thesis is to develop and validate a signal processing tool able 
to facilitate the interpretation of intracardiac electrograms. Specifically, the major aim is to 
define the process to easily obtain phase maps, action potential duration (APD) and 
conduction velocities (CV) of the heart based in an intracardiac electrogram (EGM) single 
catheter. All phase maps, action potential duration and conduction velocities provide 
relevant information related to the trigger and maintenance of atrial fibrillation (AF). 
A novel signal processing tool will be developed and validated by using as gold standard 
optical mapping data in isolated porcine hearts perfused in a Langendorff system. Electrical 
and optical mapping recordings will be performed simultaneously to ensure the validation 
process of the software created. 
The process followed in the development of this bachelor thesis may be summed up as: 
● Bibliographic study and review of existing literature related to atrial fibrillation and 
more specifically about interpretation and obtainment of intracardiac EGM. 
 
● Data recording from isolated swine heart experiments: 
 
o Preparation and setup. 
o Protocol development: catheter, pace rate and recording mode selection. 
o Development of an optimized protocol. 
 
● Development of the signal processing software for the analysis of intracardiac EGM 
signals: 
 
o Phase maps achievement. 
o Action Potential Duration calculation. 
o Conduction Velocity calculation. 
● Validation and interpretation of results. 
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Background 
This section is aimed to review the theoretical fundamentals in which this bachelor thesis 
has been sustained. This project is intended to develop a software tool to analyse biological 
data so both clinical and technical background will be explored. 
Heart anatomy & physiology 
The heart is an organ located in the middle region of the thoracic cavity. It is composed of 
four chambers: left and right atria, and left and right ventricle Figure 1. Atria and ventricles 
are separated by the intraventricular septum. Its main function is to pump blood to the 
whole organism supplying both oxygen and nutrients to the entire body and assisting in 
removing metabolic wastes as well [18]. 
 
Figure 1. Anatomy of the heart [18]. 
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Heart pumps blood through two different circulatory systems: systemic system (left side) 
and pulmonary circuit (right side).  The first one receives oxygenated blood from the lungs 
and pumps it to the whole body. The second one, the pulmonary circuit, receives 
deoxygenate blood from the body and pumps it to the lungs to be oxygenated [19]. 
Contraction of the heart, and thus pumping of the blood, is produced because of the 
electrical stimulation of cardiac cells called cardiomyocytes. The heart rhythm is self-paced 
due to its inherent and rhythmic electrical activity. It is crucial to maintain the rhythm on 
the conduction system to ensure that the atria and ventricle contract in a coordinated 
manner and avoid irregular beating of the heart that can result in arrhythmias (abnormal 
beating) [20]. 
Under normal conditions, the conduction system works as shown in Figure 2. Stimulus arises 
from sinoatrial Node (SA node) (located in the right atrium) which is referred as the 
pacemaker of the heart. It spontaneously generates electrical impulses that spread across 
both left and right atria resulting in atrial contraction (atrial systole, ventricular diastole). 
Then the impulse reaches the atrioventricular node (AV node), located on top of the 
intraventricular septum, that grant the conduction pathway between atria and ventricles.  
Next, impulses pass into the AV bundle or bundle of His and to the respective Purkinje fibers 
of each side of the heart that are able to rapidly transmit cardiac impulses from the bundle 
to the myocardium of ventricles.  Ventricular contraction (ventricular systole, atrial diastole) 
is enabled thanks to this rapid conduction and blood exits the ventricles via pulmonary 
artery and aorta. 
In case the SA node is damaged or malfunctioning, AV node cells would act as pacemaker. 
In the event of lack of coordination between both or malfunctioning an abnormal beating, 
an arrhythmia, is expected. Also, problems in the conduction system (as in the case of scars, 
anatomic obstacles) would lead to the appearance of an arrhythmia (that will be discussed 
later). 
Cardiac electrical activity is the result of the propagating action potential in cardiac cells. 
Changes in the ion concentration across cardiomyocytes cell membrane results in changes 
in membrane potential which are the driver of the action potential. Hence, repolarization 
and depolarization of membrane potentials are the reason of electrical conduction in the 
heart. While action potential spreads through the heart electrical currents that can be 
detected at the surface of the body are generated.  
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Figure 2. Conduction system of the heart. Impulse arises from the SA node and arrives to the AV node. 
Contraction of the atria is followed, under normal conduction, by the contraction of the ventricles [20]. 
 
Cardiac electrical activity is the result of the propagating action potential in cardiac cells. 
Changes in the ion concentration across cardiomyocytes cell membrane results in changes 
in membrane potential which are the driver of the action potential. Hence, repolarization 
and depolarization of membrane potentials are the reason of electrical conduction in the 
heart. While action potential spreads through the heart electrical currents that can be 
detected at the surface of the body are generated.  
An electrocardiogram (ECG/EKG) is the recording of these electrical signals and its 
morphology provides useful information of the overall cardiac electrical activity. The PQRST 
complex is the signal resulting from the ECG recording. Characteristic morphology of this 
signal provides information about the electrical status of the heart. Atrial depolarization 
coincides with the initial P-wave of the ECG. Depolarization of ventricles results in the QRS 
complex. (atria repolarization occurs at the same time but is not visible in the ECG 
recording). Final T-wave corresponds to the ventricle repolarization. The resulting PQRST 
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complex registered in the ECG is shown in Figure 3, as well as the multiple signals from the 
conduction pathway of the heart that conforms it. 
 
Figure 3. Electrical signals in the different points of the conduction pathway of the heart and the resulting 
PQRST complex registered in an ECG [21]. 
 
Arrhythmias: Atrial Fibrillation 
When normal sinus rhythm of electrical activity is disrupted, the heart suffers a cardiac 
arrhythmia. Heart beating may be accelerated, decelerated or irregular during an 
arrhythmia. Rhythm disturbance may be a consequence of disorders in impulse formation 
or conduction or a combination of both [18]. 
Arrhythmias may be classified according to cardiac frequency into tachyarrhythmias 
(accelerated rhythm, over 100 beats per minute) or bradyarrhythmias (decelerated rhythm, 
less than 60 beats per minute) [22], [23]. Firsts are much more common and can be in turn 
subdivided into supraventricular and ventricular tachyarrhythmias. Among 
tachyarrhythmias, Atrial Fibrillation (AF) is the most common one [5] and may lead to heart 
failure, stroke and other complications. 
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This bachelor thesis focused on the identification of phase maps, APDs and CV, biomarkers 
related to AF.  Current section is aimed to give an overall knowledge about AF to ease the 
comprehension of the project itself. 
Atrial Fibrillation 
As previously mentioned, AF is the most common type of tachyarrhythmia and the leading 
cause of stroke [24], [25]. Mechanisms underlying the trigger and sustaining of this 
arrhythmia are still not clear and considerable research is being performed to better 
understand AF. During AF both left and right atria beat irregularly and chaotically as it can 
be seen in Figure 4 where the impulse arises randomly [26]. This chaotical beating 
compromises the coordination between atria and ventricles. AP propagation does not arise 
from the SA node but from other atrial places leading on arrhythmic and fast atrial 
contractions that are not followed by ventricular contractions. 
 
Figure 4. Chaotical activation during AF (top) and resulting AF ECG signal (bottom) [26]. 
 
According to the recurrence of AF it can be classified into recently diagnosed (first 
symptomatic episode), paroxysmal (self-terminating, duration diverges from minutes to 
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days) and chronic or persistent AF (it lasts over 7 days and does not remit spontaneously) 
[27]. 
Mechanism underlying the maintenance of AF is not known yet and several hypothesis 
states different theories. Main hypothesis can be reduced to three: multiple wavelet, 
ectopic foci and rotor hypothesis [28] whose mechanism is schematized in Figure 5. 
1. Multiple wavelet hypothesis states that several spreading chaotically wavefronts 
across atria generate AF [9]. However, experimental data and the increasing success 
in ablation therapies contradicts this theory [28]. 
 
2. Ectopic foci hypothesis states that in atrial tissues wavefronts arising from focal 
sources of high frequencies become fractionate maintaining this way the AF [10]. 
 
3. Rotor hypothesis states the AF is an organized process in the spatio-temporal 
domain and triggered by rotors or functional re-entries at high frequencies focal 
points that generates turbulent activation in the surroundings. Moreover, this 
hypothesis for the underlying of AF mechanism is compatible with the presence of 
multiple wavelets and ectopic foci [28]. 
 
Figure 5. Illustration of the main three hypothesis for AF maintenance. From left to right: multiple wavelets, 
ectopic focus and rotor hypothesis [28]. 
Regardless of the different hypothesis, it is known that for an episode of AF to occur, a 
trigger is needed as well as a substrate that enables the re-entrant activity [9]. Eliminating 
the trigger may be enough to treat paroxysmal AF. In persistent AF cases the process is more 
complex because the atrial has undergone a process of electrical and structural remodelling. 
Changes in atrial tissues modifies its properties turning it into more prone to the sustaining 
of the chaotic activity [29]. 
The remodelling process may be due to the underlying cardiac condition, aging or because 
of the presence of the AF itself [30]. Persistent presence of atrial fibrillation may cause the 
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appearance of fibrosis due to the reduced contractility [31]. AF causing remodelling favours 
the increasing nature of tachyarrhythmia.  
Among the properties that when modified favour the maintenance of the AF some 
important biomarkers are found. Shorter AP duration (APD), short refractory period or 
decreased conduction velocities are an example [32]. It is demonstrated that reduced CV 
makes the substrate likely to maintain the AF [11], [29]. Specifically, this thesis focuses on 
the development of a software able to compute atrial CV as an indicator of areas prone to 
harbour AF.  
Atrial Fibrillation: treatment 
Current treatments for AF involve both pharmacological and non-surgical interventions 
[33]. Administration of anti-arrhythmic drugs, electrical cardioversion and catheter ablation 
are the current methods used to restore sinus rhythm while AF although the success rate 
of these treatments is not optimal [29], [34]. 
• Pharmacology therapy: anti-arrhythmic drugs 
Anti-arrhythmic drugs are intended to provoke a pharmacological cardioversion, dealing 
with both the source and the symptoms of the arrhythmia [34] ,[35]. As a prevention also, 
anticoagulant drugs may be administered in order to prevent blood clots and thus stroke 
prevention. 
• Non-surgical interventions 
a) Electrical cardioversion 
Electrical cardioversion is a medical non-surgical procedure that aims to restore sinus 
rhythm of the heart involving the delivery of a controlled electrical discharge through the 
chest wall producing an electric shock. Result of the cardioversion can be observed in ECG 
signals as the one in Figure 6, where it is also shown the pre-cardioversion ECG signal and a 
schematization of the process. Electrical impulse is delivered via a defibrillator [36]. 
However, this treatment is not intended to solve the source of the arrhythmia so 
consequently patients can suffer another AF episode in the future. 
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Figure 6. Electrical cardioversion procedure. ECG signals pre- and post- cardioversion are shown (left top and 
bottom respectively) where it can be seen how the irregular atrium beats stops. A scheme of the procedure 
including the patient and the operator (right) is represented [37]. 
. 
b) Catheter ablation 
In persistent AF when the other treatments are no longer effective a catheter ablation 
procedure is performed.  This one is the most aggressive of the treatments although the 
most effective one [38]. Radiofrequency catheters are used to isolate via cauterization the 
region of tissue where the electrical disturbance is supposed to arise of as it is exemplified 
with two of the ablation catheters available in the market in Figure 7. Despite their higher 
efficacy their results are not long-term proved and up to 43% of patients have recurrence 
in the following firsts months after the procedure [28]. 
Several approaches may be taken to proceed to the ablation but the most common one is 
the Pulmonary Vein Isolation (PVI) because of its arrhythmogenicity. PVI ablation method 
consists on atria isolation by ablation around the pulmonary veins [39]. 
Recent approaches suggest that locating the focal source of AF and using it as a target for 
this procedure will increase its effectiveness. Moreover, not only effectiveness but also 
times in the ablation procedure would be reduced which benefit the patient. Both 
increasing effectiveness (procedures may not need to be repeated) and reduced time 
impact in the total cost of the procedure, which will be reduced. Intense research is being 
performed on this subject [40], [41].  
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Figure 7. Radiofrequency ablation: ablation catheter (blue  straight one) is cauterizing the surrounding area 
of the pulmonary veins signalized by the mapping catheter (purple circle one) [42]. 
Cardiac navigation: Intracardiac EGM and catheters 
Intracardiac EGM are the record of electrical potential changes (as the previously 
mentioned ECG), but taking directly from the surface tissue of the chambers of the heart. 
Recordings are performed through a catheter that is introduced via the femoral vein up to 
the heart where the registration takes place. 
Intracardiac EGM are used as electrical references during electrophysiological studies and 
may be a very useful tool in guided ablation therapies or for the assessment of cardiac 
electrical status. Problem arises from its difficult interpretation and its variable morphology 
depending on recording mode or catheter size and shape utilized.  
• Analysis of Intracardiac EGM 
One of the main approaches utilized when it comes to the analysis of intracardiac EGM is 
the calculation of the Local Activation Time (LAT) from which biomarkers as CV are later 
computed.  Problem is that LAT calculation is strongly related with the recording mode of 
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the intracardiac signal: unipolar or bipolar (although investigation with other type of 
recordings as omnipolar is being performed as well [43]). Unipolar recording allows for an 
easy calculation of LAT point but has to face with far-field signal issues, whereas bipolar 
EGM avoids far-field signals but it is orientation-dependant [44]. Time and frequency 
approaches to analyse intracardiac EGM activation rate are validated with optical mapping 
(OM) (the same validation that was performed in this thesis) showed that results were 
unrelated [17]. 
Although there is no current validated method to compute APD and CV (the ones existing 
showed to not correlate well with OM data) significative advances are made regarding to 
processing algorithms for intracardiac electrograms. Most relevant ones include calculation 
of the phase of the signals since it is a robust method and it does not depend on the 
amplitude of the signal [45]. To compute instantaneous phase, Hilbert transform (HT) is 
frequently used [46], [47]. Kuklik et al. developed an algorithm based on wavelets 
decomposition an Hilbert Transform to accurately calculate in sinus rhythm phase of 
intracardiac unipolar signals [46]. Phase calculation as a mean to further interpret 
intracardiac EGM signals as the example of identification of focal points during AF (that are 
the main target for ablation therapies) in mathematical simulations [48] where it is also 
proposed a method to be able to interpolate phase signals coherently. 
• Catheters 
Radiofrequency and diagnosis catheters are both intracardiac catheters that can be used 
during the same electrophysiological intervention. A broad spectrum of both catheters 
types is available from the principal trading houses as Medtronic, Boston Scientific, Abbott 
or Biosense Webster. 
Specifically, some examples of mapping catheters are shown in Figure 8 . As it can be seen 
there are multiple possible shapes for the catheter and for its size. Each shape and size can 
represent an advantage from another one depending on the intended purpose. 
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Figure 8. Intracardiac catheters. A: Decapolar (Biosense Webster); B: Pentarray (Biosense Webster); C: Basket 
catheter (Boston Scientific); D: Spiral Catheter (Abbot). 
During this bachelor thesis different catheters were testes but the final results analysed and 
showed, were performed with two catheters that are being developed and tested in the 
Laboratorio de Investigación Traslacional en Cardiología del Gregorio Marañón [49]. 
Specifically, they are two catheters, pentarray-like geometry, with the same shape but in 
different sizes with five arms and three electrodes each (15 electrodes per catheter) one 
with an electrode configuration and density as shown in the image below [Figure 9].  
 
Figure 9.  Electrode configuration of the catheters utilized. (A) large size; (B) small size. 
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AF biomarkers:  CV and APD 
Alterations of the tissue can lead to modified propagation of the impulse through the 
cardiac tissue and lead to a reentry around which AF can start. Case of alterations that can 
alter the normal conduction of the heart and thus are related with AF initiation are slower 
conduction velocities and shorter APDs [Figure 10]. 
 
Figure 10. Cardiac Action Potential (blue) and APD (red): interval between depolarization and repolarization 
of the cell. 
Relation between slow conduction velocity is exemplified in Figure 11 from t1 to t4 with the 
steps leading to a re-entry. When there is a zone of slow conduction in the cardiac tissue 
(Figure 11, t1), impulse propagates around the slow CV zone and depolarizes faster than 
slow CV area (Figure 11,t 2). This leads to a situation in which when the slow CV area gets 
depolarized, impulse cannot propagate straight since it has been already depolarized due 
to the propagation of the impulse in the normal conduction regions (Figure 11, t3). 
Consequently, impulse emerging from the slow CV area changes direction and a reentry is 
produced around the region (Figure 11, t4). So that is why, as previously mentioned slowed 
CV is associate with a higher probability of arrhythmia [50]  and thus it becomes crucial to 
be able to measure it in patients. Determining areas of slow conduction velocity is key to 
direct the ablation therapy towards this proarrhythmic area, and therefore improve the 
ablation therapy efficiency and reduce the time of the intervention.  
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Figure 11. Reentry relation with slow conduction velocity. 
The same mechanism relates the shortening of APDs with the formation of re-entries. When 
action potentials duration is shortened, impulse propagation in the region is faster than 
usual, an equal region of depolarized and repolarized in the surrounding tissue led to the 
formation of the reentry around the area of shortened APDs. As in the previous case 
changes in this value are related to the trigger of an arrhythmia, in this case, shorter APD 
periods are related to an increased probability of an arrhythmia to occur [51] and thus, it 
was selected for the intracardiac EGM analysis. 
Langendorff system 
In cardiac ex-vivo experiments, it is common practice to maintain the organ alive and with 
its electrical properties intact for the adequate analysis of mechanical and 
electrophysiological properties. To do so, the organ is placed into a Tyrode-perfused 
Langendorff system [52], [53] as the one in the Figure 12. 
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Figure 12. Langendorff system set-up. From left to right: optical mapping system, cannulated isolated heart, 
perfusion circuit, pumps. 
• Isolation of the swine heart  
Isolation of the swine heart is realized according to the current legislation in the proper 
facilities intended for that purpose. Once extracted from the animal the organ is immersed 
into a Cardioplegic solution at 4°C for its cannulation and further transportation. 
Cardioplegic solution is intended to induce cardiac arrest by lowering the temperature and 
reducing cell metabolism to a minimum, therefore preserving the tissue effectively. When 
immersed in Cardioplegic solution a cannula is introduced in the aorta of the swine heart as 
in Figure 13. By means of the cannula the organ is later connected to the Langendorff circuit 
[54].  
 
Figure 13. Cannulation of the heart. (A): Cannulation occurs when the organ is immersed in Cardioplegic 
solution  and cannula is introduced in the aorta (middle, right); (B) [54]. 
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• Langendorff circuit set-up 
Langendorff system is a is a technique that allows the maintenance of an organ ex vivo 
thanks to perfusion of an oxygenated and rich in nutrients buffer. As previously mentioned 
for the purpose of this project swine hearts were utilized.  
Once the heart is cannulated and located in the Langendorff set-up, it is perfused in a 
reverse fashion (regressively down the aorta). Due to the retrograde perfusion Tyrode flows 
through the coronary arteries. Retrograde perfusion may be performed in two modes: 
constant pressure or constant flow and therefore different pumps may be utilized. 
A crucial parameter for heart stability is temperature. The perfusate must be at a constant 
physiological temperature of 37°C. Heat pumps or heat baths might be used among others. 
Not only at a constant temperature but at physiological pH: both perfusate and Cardioplegic 
solution must be pH-adjusted prior of the beginning of the experiment. 
Variation of physiological parameters alters the heart’s normal behaviour and therefore 
may lead to a misinterpretation of results. 
• Perfusate 
Different buffer solutions may be used as a perfusate in the Langendorff system. In the case 
of Langendorff heart experiments Tyrode is usually utilized.  
Tyrode is a buffer solution containing glucose, sodium, calcium, magnesium and some other 
components that provides the heart with nutrients and electrolytes necessaries for its 
proper functioning. Tyrode is pH-adjusted and then heated once introduced in the circuit 
thus the perfusate reaches the physiological conditions of the heart. 
• Oxygenation of the perfusate 
Perfusate utilized in the Langendorff system must be adequately oxygenated so the heart 
receives its proper oxygen intake. An oxygenator is utilized for this end and usually carbogen 
mix is selected. Depending on the oxygenator election it may work as not only an 
oxygenator but also a filter in order to ensure the optimal conditions of the buffer arriving 
to the heart. 
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The presence of air bubbles could cause irremediable damage to the heart therefore several 
bubble traps are placed in the circuit: after the oxygenator and in the cannula inserted in 
the aorta as an ultimate barrier for the air. 
• Pacing and ECG assessment 
Through the use of different catheters, it is possible to both monitor (electrocardiogram 
register in an oscilloscope) and pace the heart. Usually the heart once perfused naturally 
beats in sinus rhythm although it not may occur and a defibrillator may be used. Once the 
mechanical activity of the heart is stopped (as it will be explained later) and the pacing 
protocol starts.  
Optical mapping 
Optical mapping (OM) is an imaging technique that utilizes voltage-sensitive or calcium-
sensitive dyes to obtain information about transmembrane voltage changes and calcium 
transients with high spatiotemporal resolution. It is possible to perform optical mapping 
studies from single cells (in vivo) to whole hearts (ex vivo). It eases the understanding of 
electrophysiological properties of cardiac tissue and cardiac function itself.  Further study 
of the data obtained provides information about electric propagation, allow to understand 
the mechanism underlying cardiac arrhythmias and is also used in the development and 
assessment of different treatment strategies of cardiovascular diseases among other uses 
[55]. 
OM is a validated technique with enormous relevance in basic research [53] that allows the 
performance of simultaneous electrical recordings hence its use as the gold standard for 
this thesis. Because of the great importance of this technique in the validation of the results, 
in the following paragraphs it will be explored more in detail. 
To carry out optical mapping experiments a set up made of a light source and detector 
(schematized in Figure 14) as well as filters and fluorescent dyes is needed.  
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Figure 14. OM light and camera set up. 
 
The basic functioning of the OM experiments is as shown in Figure 15. A voltage-sensitive 
dye is utilized. The dye binds to the membrane of the cardiomyocytes of the heart. The 
heart is illuminated with a light source with a specific wavelength corresponding to the 
absorption spectrum of the dye in order to excite it. Photons are emitted from the dye when 
returning to ground state. Emitted photons are filtered and redirected to the detector. The 
extent of emitted photons is quantified for each pixel of the detector as a measure of the 
membrane potential changes in the heart. 
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Figure 15. Scheme of the OM set up and data acquisition. Excitation light hit up onto the dyed heart. Once 
excited the dye bounded to the cell membranes of the organ emit photons that are filtered and redirected to 
the detector that registers sequentially in time [55]. 
  
• Motion artefact 
When dealing with optical mapping of the heart an important issue must be considered: 
motion artefact. Due to the intrinsic movement of the heart signals recorded in optical 
mapping would be affected with this disturbance. To cope with this artefact, an 
electromechanical uncoupler (it prevents the mechanical movement of the heart unaltering 
the electrical conduction) might be administered to the heart and/or custom pre-processing 
treatments to the signals must be applied.  
• Fluorescent dyes: Potentiometric dyes 
Two types of fluorescent dyes are utilized in optical mapping: Potentiometric dyes, which 
accounts for changes in membrane potential, and Calcium sensitive dyes, which are used as 
indicator of cardiac excitation-contraction coupling (Calcium plays a main role in this 
coupling). Due to the rapid optical response of voltage-dependant of fast-voltage sensitive 
dyes, APD can be measured and thus they are utilized in cardiac electrophysiology [56]. As 
in this thesis optical mapping was APD calculations and voltage-related information such as 
the CV of the impulse just potentiometric dyes are briefly reviewed [57]. 
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Potentiometric dyes can be used to measure membrane potential values in whole hearts 
[58]. These dyes have the characteristic of linearly changing its fluorescence as membrane 
potential varies (within the physiological parameters) [59]. 
The mechanism of action of voltage-sensitive dyes is explained by two theories: 
electrochromic and solvatochromic theory. First one states that an alteration in the 
electronic transition is produced due to an electronic redistribution whole excitation of 
membrane potential [60]. The solvatochromic states that the dye molecules suffer a change 
in polarity (and they are reoriented in the lipid environment) due to an electric field [56]. 
Thus, depending on the mechanism of action and response time potentiometric dyes are 
divided in fast-response (electrochromic mechanism) dyes and slow-response 
(solvatochromic mechanism) dyes [57]. Because of its fast response (order of 
microseconds), fast-response dyes are utilized in cardiac electrophysiology. Specifically, the 
most common ones are styryl dyes. Example of styryl dyes widely utilized in cardiac 
electrophysiology studies is the di-4-ANEPPS. This dye decreases its fluorescence emission 
in response to increases of membrane potential (hyperpolarization) when excited at proper 
wavelengths. Di-4-ANEPPS also present high signal to noise ratio (SNR) and respond to short 
excitation wavelengths [56]. 
• Light source 
Proper illumination, stable and uniform, at the correct wavelength is key to success in 
optical mapping experiments [57]. Lately the use of light-emitting-diodes (LEDs) in 
confrontation with traditional light sources (xenon, mercury or halogen maps) is used for 
cardiac optical mapping. They offer more stability and some advantages as energy 
efficiency, portability flexibility and lower costs [61]. Adequate cooling and output power 
are some concerns related to the used of LED illumination [57].  
More intense excitation produces larger emitted fluorescence which results in larger 
signals. However, continuous illumination may result in photobleaching so the dye is only 
illuminated (and therefore excited) the necessary recording time [62] (usually optical 
mapping experiments are performed in darkness with the exception of the LED illumination 
when exciting). 
• Filters 
Filtering is aimed at reducing background light and to only let selected wavelengths reach 
the detector. Excitation and emission filters are used. Excitation filter only allows the 
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exciting dye wavelength to pass while it blocks emission light at that specific wavelength 
[56]. High-quality filters also reduce the possibility of the photobleaching effect. They are 
intended to better select the wavelength spectrum and to obtain better and with high 
quality images. 
• Detectors 
Photodetectors in cardiac optical mapping must be high-speed (because of the speed 
propagation of the electrical impulse) and low-noise (because of the weak signal strength 
produced by voltage-sensitive dyes). Detectors commonly used in cardiac mapping that 
fulfil this high spatiotemporal resolution criteria are: photodiode arrays (PDAs) and Charge 
Couple Device (CCD) cameras [57].  
CCD cameras offer higher spatiotemporal resolution than PDA (larger pixel quantity) but 
slower full-frame-rate in contrast. This slow frame rate might be improved by an increase 
in pixel binning (more than one-pixel red at a time) but will result in a decrease of spatial 
resolution. This might be a problem in experiments dealing with monolayer cell culture. CCD 
cameras derivatives are developed to avoid this concern and provide more sensitivity with 
lower noise: electron-multiplying CCDs (EMCCD) and intensified camera systems [61]. 
In the case of this thesis, the Optical Mapping set-up had EMCCD as a detector. This 
technology makes use of impact ionization (avalanche process) prior to the conversion to 
an electric e signal to produce secondary electrons. The modification to the CCD camera 
resulting overall better efficiency [63]. 
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Materials and Methods 
The current section is intended for the description of the materials used and methods 
followed during the development of this bachelor thesis. As previously mentioned, the aim 
of this project is to develop a software tool able to compute conduction velocities and 
action potential duration from intracardiac electrogram signals. To do so and to perform an 
optimal gold standard verification, electrical signals are recorded simultaneously along with 
optical mapping ones. Both registers are further analysed independently and contrasted to 
assess the efficacy of the elaborated software. 
 
Figure 16.Overall briefed workflow of the project: (A) Isolation of swine hearts and experimental set-up; (B) 
Simultaneous electrical and optical mapping registration of cardiac electrical activity or the heart; (C) 
software development and standard gold data collection; (D) Evaluation and validation of the results 
obtained. 
 
In Figure 16 the overall workflow of the project is summarized. Down below this section the 
different parts represented in the scheme will be further elaborated. 
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Experimental set-up 
• Swine heart isolation 
Optical and electrical signals were obtained from an isolated swine heart (race: Minipig) 
[Figure 17].  Organs utilized in the experiments performed for this thesis were isolated in 
the Hospital General Universitario Gregorio Marañón, Unit of Experimental Medicine and 
surgery department. All experiments were approved by the Ethics Committee on Animal 
Experimentation (EAEC) of the hospital and following the indications of the Helsinki 
convention as well as the European and Spanish regulations on the subject. In particular, 
the hearts were isolated by thoracotomy after the general anaesthesia. 
 
Figure 17. Isolated swine heart. 
Once isolated hearts were introduced in Cardioplegic solution at 4°C to cease its activity. 
While introduced in the Cardioplegic solution were cannulated through the aorta and 
transported to the lab afterwards.  Cannulas were designed in the Laboratorio de 
Investigación Traslacional en Cardiología using Meshmixer tool, 3D printed and ensembled 
with the necessary tube and tube connectors. 
25 
 
• Langendorff set-up 
The cannulated organs were placed into the Langendorff set-up. Swine hearts were 
continuously perfused with a bubbling carbogen-oxygenated Tyrode solution of 95% 𝑂2 and 
5% 𝐶𝑂2. 
An oxygenator [Figure 18 A] D 901 Lilliput: Hollow Fibre Oxygenator with Twin Reservoir 
was utilized along two peristaltic pump Masterflex L/S model number 7524-45, 10-600 RPM 
assembled in USA by Thermo Fisher Scientific, each one for the incoming and outcoming 
circuit respectively. Input flow was set to 170 ml/min and output flow to 200 ml/min. A 
water bath [Figure 18 B] from Anova Industries, Inc,A&C Model, series- E of 220 volts, 50 Hz 
and 1000 watts was utilized to enable a nearby physiological temperature of 37°C in all 
circuit. 
 
Figure 18.(A) Oxygenator; (B) (from left to right) Water bath and peristaltic pumps. 
 
Data acquisition: simultaneous recordings  
Data collection of this thesis was obtained from swine isolated hearts perfused in 
Langendorff system experiments. Experimental data collection was integrated as a part of 
the development of the experiments for a larger project being carried out in the Laboratorio 
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de Investigación traslacional en Cardiología of the Hospital Gregorio Marañón. Protocols for 
both projects were joint together in order to develop the experiments jointly as they did 
not interfere one with each other (the protocol for this thesis was designed to be developed 
in non-fibrillation rhythms while the second protocol was intended for AF measurements). 
A total of 7 experiments were performed for the development of this thesis. Both the 
software and the experimental protocol suffered an implementation process that resulted 
in the fulfilment of this project’s objective. Results presented in this thesis are the ones 
obtained with the data recorded in the last experiment, technical problems with some 
equipment utilized made invalid signals so the number of results presented in this thesis is 
reduced. 
 
• Optical mapping register 
Hearts were infused with 100 μL bolus of di-4-ANEPPS (Biotium, Inc. Hayward, CA, USA) of 
4.16 mM (in DMSO) applied over 5 minutes following electromechanical dissociation by the 
administration of 10 mM of 2,3-butanedione monoxime (Biotium) in Tyrode solution.  
In order to excite di-4- ANEPPS, hearts were illuminated with a filtered green LED light 
source: LED: CBT-90-G (peak power output 58 W; peak wavelength 524 nm; Luminus 
Devices, Billerica, USA), plano-convex lens (LA1951; focal length= 25.4 mm; Thorlabs, New 
Jersey, USA) and a green excitation filter (D540/25X; Chroma Technology, Bellows Falls, 
USA). Such light sources were used to achieve homogeneous illumination. In order to excite 
di-4- ANEPPS, hearts were illuminated with a filtered green LED light source: LED: CBT-90-G 
(peak power output 58 W; peak wavelength 524 nm; Luminus Devices, Billerica, USA), 
plano-convex lens (LA1951; focal length= 25.4 mm; Thorlabs, New Jersey, USA) and a green 
excitation filter (D540/25X; Chroma Technology, Bellows Falls, USA) [64]. Custom software 
written in MATLAB and based on Micro-Manager Open Source Software was used to 
perform optical mapping image recording and processing [Figure 19]. 
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Figure 19.Optical mapping registration process being carried out; (right) optical mapping setup for isolated 
Langendorff perfused hearts. 
 
• Electrical register 
Electrical recordings were initially performed with a Decapolar St. Jude catheter [Figure 9 , 
A] performed on the isolated organ with different types of intracardiac catheters that are 
being develop in the laboratory [ Figure 20 B], [49]. 
 
Figure 20. Intracardiac EGM catheters: (A) St. Jude Decapolar; (B) 5-arm laboratory catheter. 
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Two five-arm catheters of different sizes were connected to a 64 channel-polygraph with 
reference placed in the right ventricular tract (none electrical activity). 
Decapolar catheter registers were only performed in the very first experiments, later on 
because of the better properties offering the pentarray ones replaced it. Reasons of the 
mentioned catheter include geometry of the pentarray (it better fit atria, the region of 
interest) and it lends itself for a better interpolation (further details are provided in the 
software development section). 
Because of the different morphology of the atria between the different hearts it was 
sometimes necessary to dilate the atria for the catheter to fit onto its surface. Dilatation of 
the atria was performed by intracardiacally introducing and inflating a balloon, as some 
clinical catheters allow the same procedure. 
All electrical recordings were registered in unipolar mode during 10 seconds with a sampling 
frequency of 1 kHz. 
• Electrical Pacing and assessment 
Two additional catheters were used: one for pacing the heart and another for EGM 
monitoring, connected to an oscilloscope (this way heart rhythm can be monitored and 
status of the heart checked) in real time.  
Pacing protocol consisted in the application of a biphasic pulse of 4V and varying pacing 
intervals, ranging from 300 ms to 1000 ms, to ensure that the algorithm works for a 
physiological range of heart rhythm from the atria epicardium so that the propagation was 
longitudinal to epicardial fibre orientation. 
Software development 
In this section the process for obtaining CV and APD will be described step by step. An 
overall summary of the whole process is shown in [Figure 21] 
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Figure 21. Workflow of the software tool. 
 
• Signal pre-processing 
Signals were pre-processed in order to remove noise and enhance the features of the 
signals that were necessary for the further development of the code [Figure 22, A and B]. 
Pre-processing consisted on drift removal and filtering. To estimate the baseline, ECG 
signals were decimated to 51.2 Hz and filtered with a Butterworth 10th-order low-pass filter 
with a cut-off frequency of 2 Hz.  Baseline was then interpolated to 1000 Hz and subtracted 
to the original signal. 
• Botteron Approach 
Botteron approach performs a transformation on the signal in order to emphasise the 
fundamental frequencies and, in the case of this project, it serves because of two reasons. 
First it recognizes the depolarization and repolarization along the signal as signalled with 
the green and red arrow respectively in Figure 22, C. By eliminating the repolarization peak 
it serves to calculate the period and also the phase (Kuklik’s algorithm is applied to Botteron 
signal after the elimination of repolarization peak). Botteron approach includes absolute 
value computation and low-pass filtering at 20 Hz.  
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• APD Calculation 
From the signals obtained after the application of the Botteron Algorithm, APDs were 
straight calculated after identifying the peaks present in Botteron signal. By computing the 
intervals between peaks signalized as in the Figure 22 D APDs were obtained. As previously 
mentioned, depolarization occurs at different times but repolarization within a vicinity of 
the tissue occurs at practically the same instant. 
• Period calculation 
Period was computed by performing Welch Periodogram with Hamming window of double 
length of sampling frequency, i.e. 2000, Fast Fourier Transform of 4096 points and 50% 
overlap of the Botteron signal (after eliminating the repolarization peaks) 
• Phase Calculation 
Phase is computed using the algorithm proposed by Kuklik et al [46] that is based on the 
sinusoidal reconstruction (wavelets) of the Hilbert Transform. As an example of the phase 
signal obtained is showed in Figure 22 E: values in the range of π and -π. 
 
• Phase Interpolation 
Once phase is calculated the objective was to interpolate the phase data to an 81x81 grid 
matrix from a geometry created to emulate the actual morphology of the catheter used 
Figure 22, F. The 81x81 grid was utilized to represent a square of 20x20 mm in 0.25 mm 
steps where both catheters arms, large and small, were able to fit (r=7mm and r=8mm 
respectively). 
First of all, to interpolate the phase first it was transformed to a complex exponential form 
as Roney et al. proposed [48]: 
 
𝜃 →  𝑒𝑖𝜃   
Equation 1. Phase transform. 
31 
 
 
Once the transformation is performed, the transformed data is interpolated to the 81x81 
matrix by a Delaunay triangulation. Then the complex exponential form transformation is 
undone and phase maps as the ones in Figure 22 G are obtained. 
Interpolation is performed from the 15 electrodes available in both large and small 
catheters and in just 5 out of the 15. Specifically, the five outermost electrodes of each 
catheter in order to prove the response of the code to both situations and determine the 
one providing more accurate results. 
• Trajectory calculation 
Impulse trajectory is calculated as an intermediate step between phase maps obtainment 
and CV computation.  
In order to obtain the direction, the 81x81 grid is divided in 5 sections each one comprising 
one of the catheters legs coordinates. 
Once the area has been divided, to achieve better results a frame selection is performed in 
order to define the pulse intervals when the phase values is varying from -pi to pi. For each 
of these regions a determined number of time intervals to analyse (each interval 
corresponds to the depolarization interval of the pulse in the region) is selected. 
Afterwards, in each frame of these period intervals the middle point of the depolarizing 
wave is computed. Summation of all middle points along the different frames of the 
spreading of this depolarizing wave gives as a result the trajectory of the wave propagation 
as represented by the red arrow in Figure 22 H. 
• Velocity calculation 
Once the trajectories of the impulse have been calculated, in order to calculate the velocity, 
middle part of the trajectory is selected and its longitude calculated. Time interval is 
computed as the time elapsed between the depolarization at the beginning of the trajectory 
segment and the depolarization of the end of the selected segment. Velocities are then 
calculated. 
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Figure 22. Summary of signal transformation along the software code. (A) Unfiltered Signal; (B) Pre-processed signal; (C) Botteron 
signal with depolarization and repolarization peaks (green and red respectively); (D) APD computation; (E) Phase signal obtained with 
Kuklik’s algorithm; (F) Catheter configuration simulated in de code; (G) Phase maps obtained in the 81x81 grid; (H) Trajectory 
computation from phase maps. 
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Results validation  
OM data was utilized as gold standard for this thesis. Both phase maps and CV software 
results were compared as summarized in Figure 25Figure 24. 
Phase map validation was performed as a middle step in the process to ensure that the 
development of the software was going as expected. Phase maps videos were visually 
compared with the ones obtained from OM in order to check the accuracy of the method 
at this step. 
With regard of APD and CV values obtainment OM signals were subjected to a pre-
processing filter process. Steps followed included:  fifth order spatial filtering, eleventh 
order Sgolay filtering, fifth order time smoothing filtering and baseline removal. 
APD calculation was measured by computing the interval between depolarization (upstroke 
of the stimulus) and repolarization as signalized in Figure 23: 
 
Figure 23. APD calculation from OM data. 
For CV calculation and once filtered by selecting two pixels in the Guided User Interface of 
the specialized software of OM analysis, the program gives in return a value for CV between 
the two pixels.  
The program correlates the two fluorescent signals correspondent to the pixels and with a 
calibrated distance (spatial information) (that must be performed at the beginning of the 
process) the CV is calculated with the electric impulse correlation (temporal information). 
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Figure 24. Summary of the results of each step of the software development process compared 
with the gold standard ones. 
• Statistical analysis 
In order to analyse the correlation between the electrical and optical mapping data two 
steps were followed: 
1. Absolute and relative error calculation were calculated for APD and CV results. 
Since what is important is to be able to identify changes in APD and CV values, it 
was set as an acceptable result a difference on 20 ms in APD calculation and 20 
cm/s in CV calculation. This interval was selected taking into account that not 
exact measurements are required for identification of critical areas, just 
appreciation of relevant differences is needed. 
2. T-student statistic test for the acceptable results obtained from the analysis of 
the absolute errors. Since different recordings were not performed exactly in the 
same conditions (spacing rates, stimulator catheter location, time elapsed after 
heart’s isolation) data were normalised in pairs (each OM result was set as 1 and 
electrical value referred to it) to perform the test. 
Results were grouped attending to the catheter utilised or the number of electrodes 
interpolated in order to determine which was the combination that led to the most accurate 
results. 
35 
 
Results 
This bachelor thesis consisted on the development of a software tool able to compute 
cardiac AF biomarkers such as APD and CV. Even though the main effort and work was 
devoted to the development of the software, a considerable part of the project itself 
consisted on the correct execution of the experimental data collection (both the electrical 
registers and the optical mapping validation ones). 
Results presented in this section are the ones corresponding to the recordings of the last 
experiment as previously mentioned, when the implementation of the experimental 
process and of the software was completed. 
Analysis 
Although the objective was to obtain the APD and CV values and validate them with the 
ones obtained with the optical mapping data, during the process to compute them, phase 
maps and trajectories (i.e. direction of the impulse at each moment) were also obtained. 
Even if they were not further analysed more than as an intermediate step in the code 
process they might be interesting for their use in future studies. 
A statistical analysis was performed to analyse the results obtained from the signals 
recorded from the last experiment. Signals in this last experiment were recorded while 
pacing at different rates: 800, 500 and 300 ms, and with both the large and the small 
catheter in the atria of the isolated swine heart. 
Analysis: APD and CV 
In this section the results from the APD and the CV are presented. In both cases results are 
analysed on the basis of the catheter utilised and of the 5 or 15 electrode interpolation use 
in order to determine which option conferred better results. 
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• Action Potential Duration 
The developed software was able to compute APD both with the signals recorded with the 
small and the large catheter and also from utilizing the outermost 5 electrodes or de 15 
available from each catheter highly accurately. 
The algorithm estimated the APD accurately for pacing rates higher than 300 ms.  The code 
developed during this project was intended to work at nearby sinus rhythm (frequency is 
around 1 Hz). Therefore, as frequency recorded from optical mapping when stimulated at 
300 ms was around 3.5 Hz and APDs were shortened to the order of 120 ms, it is reasonable 
that the code was not able to estimate APD under these conditions. Nevertheless, software 
was able to discern if the signals recorded came from elevated, abnormal pacing rates 
(characteristic of fibrillation). 
In Figure 25 results from the APD computation are presented. As it can be observed, the 
results obtained from the processing of the EGM signals reproduced the values obtained 
from the optical mapping data. Not significant differences were observed between the 
small and large catheter capabilities to sense APDs in the recorded signals according to the 
T-Student test 
 
Figure 25. Results from APD computation and comparison with gold standard data. (*repeated 
frequency/catheter data was recorded stimulating from different location of the atria) 
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In order to ensure the code sensibility and quality of APDs recorded, an analysis including 
absolute and relative errors and T-student test was performed. 15 electrodes and 5 
electrode interpolation were submitted independently to this analysis to test whether there 
were significant differences between the two interpolations for the APDs computation. 
In Table 1 absolute and relative errors from APDs computation are presented. As it can be 
observed, all absolute errors from APDs obtained are in less than 20 ms (which is between 
the reasonable range since a difference of 20 ms represent a notable difference to discern 
two areas with different APD lengths). Relative errors obtained were always minor than 6% 
what represent highly accurate results. 
 
 
APD  
measurements 
5 Electrode  
Interpolation 
 
15 electrode 
Interpolation 
 
 
𝑬𝒂̅̅̅̅  (ms) 
 
𝑬𝒓̅̅ ̅ (%) 
 
𝑬𝒂̅̅̅̅  (ms) 
 
𝑬𝒓̅̅ ̅ (%) 
 
                                        
Small catheter 
 
8.99 4.37% 9.42 4.35% 
 
Large Catheter 
 
4.37 2.43% 10.08 5.63% 
 
Table 1. Results from APD computation: absolute error and relative errors presented. 
T-student test results comparing the APDs obtained from 5 electrode interpolation vs. 15 
electrode interpolation are showed in Figure 26. Level of confidence was set to α=0.05 and 
results did not show significant differences when p-value was higher than  α. In both cases 
of APD calculation results did not present statistically relevant differences. 
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Figure 26. T-student test results from APDs obtained from the 5 electrode interpolation (left) and 
15 electrode interpolation (right). 
• Conduction Velocity 
Conduction velocities results are presented in the following figure [Figure 27]. 
 
Figure 27. CV global results. 
Unlike APD results, the accuracy in CV results showed a higher dependency both on catheter 
utilised and number of electrode used. Results showed that CV computed were in the 
acceptable range proposed in this thesis and the results that differed too much came from 
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the 300 ms signals that, as was previously stated, was set as the limit for nearby sinus 
rhythms.  
Large catheter showed less similitude with optical mapping than the small catheter. Results 
also differed from 15 electrode interpolation and 5 electrodes interpolation ones showing 
initially a higher accuracy 5 electrode ones. Further analysis of relative and absolute errors 
as well as T-student test are presented to confirm the accuracy of the results. 
In Table 2 relative and absolute errors attending to catheter type and number of electrodes 
interpolated are shown. Accepted absolute error was considered to be 20 cm/s so , while 
all results obtained from the small catheter are in the accepted range while only the 5 
electrode interpolation (without the 300 ms signals) from the large catheter is accepted. 
This difference may be due to the fact that velocities are computed from phase maps and 
they were better computed from single circles rather than from several point not encoding 
a clear region. An implementation option would be to compute velocities from the three 
different rings of five electrodes available in each catheter. 
CV  
MEASUREMENTS 
5 Electrode  
Interpolation 
15 Electrode 
Interpolation 
 w/ 300 ms  wo/ 300ms wo/ 300 ms 
 𝑬𝒂̅̅̅̅  (cm/s) 𝑬𝒓̅̅ ̅ (%) 𝑬𝒂̅̅̅̅  (cm/s) 𝑬𝒓̅̅ ̅ (%) 𝑬𝒂̅̅̅̅  (cm/s) 𝑬𝒓̅̅ ̅ (%) 
 
Small Catheter 
 
11.33 
 
15.98% 
 
8.34 
 
11% 
 
19.72 
 
27.33% 
 
Large Catheter 
 
26.56 
 
32.9% 
 
14.45 
 
17.93% 
 
47.11 
 
58.71% 
Table 2. CV measurements error results attending to catheter type and number of electrodes interpolated. 
A T-student test was performed on the normalized results (excluding 300 ms signals) in 
order to ensure the results from the small vs. large catheter comparison. Results presented 
in Figure 28 corroborated that small catheter results correlate better with OM data and, 
moreover, did not showed significant differences. 
 To further evaluate the accuracy of the results obtained from the small catheter register 
another T-student test was performed to analyse the results attending to the number of 
electrodes used to perform the interpolation [Figure 29]. 
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Figure 28. Small vs. Large catheter CV T-student test. 
 
Figure 29. T-student test of CV results obtained from small catheter comparing 15 vs 5 electrodes 
interpolated. 
Although the absolute error obtained from the 5 electrode interpolation was less than the 
15 electrode interpolation ones, T-student test results found that differences in both groups 
of CV values obtained are not statistically significant compared to OM data. 
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Discussion  
This bachelor thesis arises from the need of a validated method for the identification of AF 
biomarkers. Hypothesis for this project was raised after an intense study of the current 
studies and existing bibliography regarding AF trigger and maintenance mechanisms and 
the limitations and problems related with their study and obtaining.  
Results obtained for APD computation are considered accurate and no significant 
differences were observed when utilizing different catheters nor when interpolating signals 
from all or just one third of the electrodes available. Catheter sensibility to detect both 
repolarization and depolarization changes in membrane potentials of the heart was proved 
as well as the code ability to properly analyse the signals in order to obtain APDs either with 
5 and 15 electrodes interpolated. Ability of the code to compute APDs with less number of 
electrodes than the available ones provides an important advantage because it implies that, 
although failure of some electrode or inability to make proper contact of some of them, 
results would still be precise. 
Regarding CV results, small catheter results both from 15 and 5 electrodes interpolation did 
not present statically significant differences and were in the variation range set as 
acceptable for CV. In particular, 5 electrode interpolation gave a higher accuracy: an 
absolute error of 8.34 vs. 19.72 cm/s (11% and 27.33% relative errors respectively). Large 
catheter results showed in general statistically significant differences with respect to OM 
data. Although results from 5 electrode interpolations with large catheter were inside the 
range of acceptable CV variations, small catheter results were better. Therefore, it can be 
concluded that the best CV results were achieved with the small catheter signals 
interpolated from 5 electrodes. 
Differences between large and small catheter may be due to the size of the catheter since 
recording in the atria, small catheter is able to make a better fit (2.5 vs. 3.5 cm). Atria surface 
is reduced, and in order to make the proper measurements and fit the catheter, sometimes 
a balloon had to be introduced inside the atria to inflate it and expand its surface. However, 
even with the large catheter, an absolute error of 14.45 cm/s (acceptable to determine slow 
CV regions, and to determine a target ablation area) was obtained.  
In conclusion, CV and APDs results presented the accuracy desired to be able to determine 
the areas prone to harbor the trigger AF and thus, set a target for radiofrequency ablation. 
Application to clinical area of the results obtained from this thesis may result in more 
42 
 
specific treatments. Currently, ablation therapy is performed by applying a general protocol 
that, in case to be able to determine the critical regions for ablation, may be designed 
specifically for each patient improving the results of the intervention and probably reducing 
the number of interventions needed, making it a long-term treatment. 
This thesis arises from the need of a validated method for the interpretation of intracardiac 
EGM signals. Considerable approaches have been made in order to analyze them and obtain 
useful information about cardiac function and its assessment. Several approaches intended 
to calculate CV from local activation time, based on cycle length and time-domain analysis 
[55]. Problem is that results are recording-mode dependent, unipolar or bipolar recording 
will greatly influence the obtained signals. Approaches intended to develop solutions for 
those interferences are also considered [43]. However, these approaches have been 
demonstrated to not correlate well when validated with OM data [17]. 
New studies suggested the use of phase as a robust method for intracardiac EGM analysis 
[45]. Kuklik et al. [46] proposed a method based in Hilbert Transform to obtain phase from 
unipolar electrograms that, although not developed for fibrillation rhythms was utilized as 
a first step for this thesis. Phase calculation was the basis for several studies that served to 
deepen in EGM interpretation as for example the one proposed for Roney et. Al [48] that 
studied the influence of spatial resolution requirements on mathematical simulations of 
EGM as well as propose the method for phase interpolation used in this thesis. However, 
none of these methods proposed a validated process to obtain biomarkers related to AF as 
this thesis is intended for. 
Software code developed in this project implemented a combination of several proposed 
intracardiac processing methods such as the previous ones mentioned as well as the signal 
processing algorithm proposed by Botteron [65]. This thesis was validated with optical 
mapping data, which is a far validated and reliable technique that, added to the fact that 
validation of the results was performed with data obtained ex vivo, results in a major 
implementation towards clinical application of the code, which is the major end of this 
technology.  
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Limitations 
This section aims to be critical with the development of the project since it is really 
important to understand the backdrops of the study and be aware of the limitations that it 
dealt with (some of which are common to related studies as well) in order to be able to 
continue developing it: 
• As it was shown in the previous section, the code was whether not able to obtain 
such biomarkers values from the 300 ms data or when computed showed a bad 
correlation with gold standard data (even the code works properly for its aimed 
function: sinus rhythm nearby 1 Hz).   
 
• Results and precision of the software, beyond the accuracy of the method itself, are 
also conditioned to the sensibility that intracardiac catheters possess themselves to 
measure the electrical changes.  
 
• One of the assumptions made in this project had to do with the geometry and 
position of the catheter during registers. Software code was developed supposing 
that the catheter was fully extended, the arms were equally distributed and fitted 
onto a flat surface. During clinical electrophysiological interventions, such as an 
ablation for example, a sophisticated localization software informs about the precise 
location of each of the catheters within the body, and thus within the heart. 
However, in the experiments performed for this thesis it was no possible to take into 
account these considerations. Variations introduced by making these assumptions, 
although thought to be small, can improve the results making them even more 
accurate. 
 
• Contact of the catheter’s electrodes with the heart’s surface may greatly influence 
the results. Although in the experiments a lot of effort was put in order to ensure 
the best possible fitting between the catheter and the heart’s tissue, some 
electrodes might not be making the proper contact. As well in a real clinical 
electrophysiological intervention this possible event must be taken into account.  
 
• Availability of signals was limited due to technical problems related with the 
electronic equipment of the Langendorff set-up and validation of results was 
performed with a reduced number of samples. 
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Future work 
The developed software in this bachelor should be further validated with an increased 
number of sample signals recorded to totally ensure its accuracy and be able to determine 
exactly its sensibility depending on the recording conditions. 
Next steps should be intended to continue the hypothesis raised during this project and 
incorporate this technology to the tools already utilized to comprehend the mechanism 
underlying and perpetuating AF. Also, software code may be implemented in order to be 
able to compute APDs and CV in real-time guiding it to a feasible clinical application. Also, 
to achieve the goal of the clinical application of the code proposed in this thesis, further 
analysis and validation must be performed in in-vivo situations and to determine the 
effectiveness of ablation of the regions detected by this code. 
Although the software developed during this project was not intended to work during the 
arrhythmia itself, natural next step should be the implementation of the code in order to 
improve its performance during close-to-fibrillation rhythms.  
Not only code-related implementation but also regarding the catheters. Another 
configurations, geometries and electrode densities could be tested in order to ensure the 
optimal performance. As a hypothesis, including a central electrode could improve the 
sensing catheter properties in general (in the case of pentarray-like catheters) and in 
particular, its inclusion, creating a more equally distributed network of electrodes, could 
improve the results of the code (as the phase interpolation results would be enhanced). 
Although it was out of the scope of this project, during the analysis of the optical mapping 
data it can be appreciated that conduction velocities within the vicinity of the catheter 
location were somehow altered. Even this fact did not alter the results of the validation 
process of the project (although the CV differed from the values of the rest of the heart they 
were the same CV values the ones measured electrically than with optical mapping) it is 
thought to be interesting to investigate and assess the effect of the catheters on the effect 
of the catheters on the electrophysiological properties of the organ. 
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Expenditure, Socioeconomic Impact 
and Legal Framework 
Expenditure  
Expenditure section will be detailed in three different parts: human resources, software 
development and data collection experiments. 
Human Resources Invested Hours Cost (€/hour) Total (€) 
Biomedical Engineer 400 20 8000 
Project Collaborator 100 35 3500 
Project Coordinator 80 35 2800 
  Total 14300 € 
Table 3. Human Resources Expenditure. 
Software Resources Units Price/Unit (€) Amortisation 
period 
Total (€) 
MATLAB®2017b 1 2000 
(perpetual) 
5 years 400 
Computer 1 800 5 years 160 
   Total 560 € 
Table 4. Software Resources Expenditure. 
Data Collection 
Experiments* 
Units Price/Unit (€) Amortisation 
period 
Number of 
experiments 
Total (€) 
Langendorff 
System set-up + 
Optical mapping 
set-up 
1 57,000 
200 
experiments 
7 1,995 
Polygraph 64 
channels 
1 12,000 
200 
experiments 
7 200 
Swine heart 
isolation** 
1 590 - 7 4130 
    Total 6325 € 
Table 5. Data Collection Experiments Expenditure. 
 
*All expenses were shared with another project developed in the laboratory. 
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** Following the cost tables of animals and procedures of the Fundación para la Investigación 
Biomédica del Hospital Gregorio Marañón where the procedures were carried out, the estimated 
cost per animal of 3 months with an estimated weight of 45kg and for the cost of renting the surgical 
room and support from the team of veterinarians and anesthetists. It is included in the cost the 
necessary fungible material (throw, fluorophores, electrodes, etc.). 
Total expenditure of the project was 21185 €. 
 
Socioeconomic Impact 
Atrial Fibrillation is the most common arrhythmia and it is expected that by 2025, 2% of the 
population would be affected by AF [66]. More than a health issue, this adds up to a huge 
economic impact on the healthcare systems [67]. 
Therefore, ideas to treat AF point in the direction of prevention and more specific 
treatments. Currently, ablation procedures are the most effective treatment for AF but lack 
of identification of focal sources of initiation of the arrhythmia make these treatments not 
long-term efficient and in need for several interventions. 
Application of this thesis to basic research may help understanding the mechanisms 
underlying the initiation and maintenance of AF and thus, helping in prevention of 
arrhythmias and improving the current treatments. 
APD and CV computation from intracardiac EGM signals allows for the identification of the 
regions prone to harbour the trigger of AF. The code was implemented for sinus rhythm 
since patients with paroxysmal AF ablation (which are the ones indicated for ablation 
therapy) are normally in sinus rhythm so by locating the regions with shortened APDs and 
reduced CV, target for ablation would be identified. Application to clinical practice would 
have an important economic impact if it allows for a real target ablation procedure: number 
of interventions will decrease, number of hospitalizations will be reduced as well and both 
human quality of life and economic impact of AF in healthcare systems will be improved. 
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Legal Framework 
As it was previously mentioned experiments with swine hearts realized for this thesis were 
approved by the Ethics Committee on Animal Experimentation (EAEC) of the Hospital 
Universitario Gregorio Marañón. 
The EAEC of Gregorio Marañón is in charge of these issues, to monitor the implementation 
of animals in the laboratory as established in current legislation. Also, it should oversee the 
project in order to check if everything is done in relation to the rights and welfare of animals, 
persons and environment. Article 38 of RD 53/2013. 
“Real Decreto 53/2013, de 1 de febrero, por el que se establecen las normas básicas 
aplicables para la protección de los animales utilizados en experimentación y otros fines 
científicos, incluyendo la docencia.” 
The EAEC has the designation of Organ enabled (OH) by the competent body in the 
Community of Madrid. The main goal of this entity is to evaluate if the projects are 
scientifically or educationally justified; if the final purpose justified the use of animals and 
its farewell. 
The EAEC will evaluate the projects proposed in the Unit of Medicine and Experimental 
Surgery of the Gregorio Marañón Hospital (UMCE) and the OH will evaluate the projects 
proposed to be carried out in the Gregorio Marañón Hospital Health Research Institute 
(liSGM). 
All staff that has been involved in the swine heart extraction/been in contact with the 
animal were correctly trained according to the RD 53/2013 and the Order ECC 566/2015.  
“Orden ECC/566/2015, de 20 de marzo, por la que se establecen los requisitos de 
capacitación que debe cumplir el personal que maneje animales utilizados, criados o 
suministrados con fines de experimentación y otros fines científicos, incluyendo la 
docencia.” 
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Conclusions 
This bachelor thesis aimed to develop a method for the computation of APDs and CVs from 
electrical recordings obtained from intracardiac catheters and to validate it through the 
values obtained from simultaneous OM data. After the analysis of the results it can be 
stated that: 
• A software code able to easily and automatically compute APDs and CV from 
intracardiac EGM signals was developed. 
 
• Results computed by the software developed from EGM signals registered in a swine 
isolated heart were validated and demonstrated to be accurate enough to 
considerate this method as valid. 
 
o Specifically, it was demonstrated that with a small catheter (2.5 cm radius) 
better results were obtained. 
o Number of electrodes interpolated was not relevant for APDs obtaining 
while regarding CV computation with 5 electrodes instead of 15 electrodes 
interpolated showed more accurate results. 
In conclusion, a software code for computing APDs and CV from intracardiac EGM signals 
was developed and validated using OM data. Computing of APDs and CV from intracardiac 
EGM can be used to identify which areas of cardiac tissue are prone to harbour the trigger 
and beginning of AF. Identification of such areas is clinically relevant because it can be used 
to obtain the ablation target in patients with paroxysmal AF. 
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